Regulatory Issues
- news/archive September 13, 2007 Federal Research Plan to Determine Nanotech Risks Fails to Deliver Almost a year in the making, a federal plan to prioritize research on the potential environmental, health, and safety (EHS) impacts of nanoscale materials has so many failings that its begs the question as to whether the government’s 13-agency nanotechnology research effort is able to deliver an effective risk research strategy, according to David Rejeski, head of the Wilson Center’s Project on Emerging Nanotechnologies.
- events/archive July 26, 2007 Where Does the Nano Go? New Report on End-of-Life Regulation of Nanotechnologies Please join us on July 26, 2007, for the release of this report featuring the authors, along with Leslie Carothers, President of the Environmental Law Institute, and David Rejeski, Director, Project on Emerging Nanotechnologies. The discussion will focus on the end-of-life regulation of nanotechnologies. video
- publications/archive July 1, 2007 Where Does the Nano Go? End-of-Life Regulation of Nanotechnologies
- events/archive May 23, 2007 EPA and Nanotechnology: Oversight for the 21st Century As the Environmental Protection Agency (EPA) recently stated, nanotechnology has evolved from a futuristic idea to watch to a current issue to address. And for this new technology’s enormous potential to improve everyone’s life to be realized, nanotechnology must be subject to an adequate oversight system—a system designed to identify and minimize any adverse effects of nano materials and products on health or the environment. video
- publications/archive May 1, 2007 EPA and Nanotechnology: Oversight for the 21st Century As the Environmental Protection Agency (EPA) recently stated, nanotechnology has evolved from a futuristic idea to watch to a current issue to address. A new report by J. Clarence (Terry) Davies considers various oversight tools for dealing with nanotechnology and proposes a number of action steps for government, industry, and other stakeholders.
- events/archive March 14, 2007 Thinking Big About Things Small New Report Looks Beyond Specific Statutes at Effective Oversight System video
- publications/archive March 1, 2007 Thinking Big About Things Small: Creating an Effective Oversight System for Nanotechnology
- publications/archive March 1, 2007 Nanotechnology and Life Cycle Assessment: A Systems Approach to Nanotechnology and the Environment
- publications/archive November 16, 2006 Safe Handling of Nanotechnology
- publications/archive October 10, 2006 FDA and Nanotechnology: Public Perceptions Matter
- publications/archive October 10, 2006 Statement of Michael R. Taylor at FDA hearing
- news/archive October 10, 2006 Nanotech Knocks on FDA’s Door “Thanks to the promise of nanotechnology, people will benefit from fantastic new prescription drugs and from better ways of getting existing pharmaceuticals into the body for more effective disease treatments. But new nano-enabled drugs and medical devices also place new burdens on an oversight agency that is already stretched extremely thin,” said Project on Emerging Nanotechnologies Director David Rejeski in a presentation today at the Food and Drug Administration’s first major public meeting on regulating products containing nanotechnology materials. video
- news/archive October 6, 2006 Project Comments Submitted to FDA in Advance of Public Hearing
- publications/archive October 5, 2006 FDA-Regulated Products Containing Nanotechnology Materials
- events/archive October 5, 2006 Regulating the Products of Nanotechnology Former Food and Drug Administration (FDA) Deputy Commissioner for Policy Michael R. Taylor analyzes FDA’s ability to properly protect the American public from the potential hazards associated with nanotechnology in a new report, Regulating the Products of Nanotechnology: Does FDA Have the Tools It Needs? video
